These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10706121

  • 21. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 22. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X, Yang X, Li L, Liu H, Liu J.
    Vaccine; 2006 Apr 12; 24(16):3321-31. PubMed ID: 16472546
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun 12; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
    Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC.
    Gene Ther; 2003 Aug 12; 10(16):1311-20. PubMed ID: 12883527
    [Abstract] [Full Text] [Related]

  • 27. Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity.
    Lin CT, Chang TC, Shaw SW, Cheng PJ, Huang CT, Chao A, Soong YK, Lai CH.
    Vaccine; 2006 Sep 11; 24(37-39):6199-207. PubMed ID: 16824651
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Ling M, Slater LA, Roden RB, Wu TC.
    Hum Gene Ther; 2001 Feb 10; 12(3):235-52. PubMed ID: 11177561
    [Abstract] [Full Text] [Related]

  • 29. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.
    Vaccine; 2006 Apr 05; 24(15):2880-93. PubMed ID: 16472545
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM, Maudoux F, Thomas S, Thielemans K, Burny A, Leo O, Bex F, Hallez S.
    Eur J Immunol; 2007 Feb 05; 37(2):376-84. PubMed ID: 17274002
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW.
    Immunol Lett; 2009 Jan 29; 122(1):58-67. PubMed ID: 19135479
    [Abstract] [Full Text] [Related]

  • 34. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 35. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.
    Ji H, Wang TL, Chen CH, Pai SI, Hung CF, Lin KY, Kurman RJ, Pardoll DM, Wu TC.
    Hum Gene Ther; 1999 Nov 20; 10(17):2727-40. PubMed ID: 10584920
    [Abstract] [Full Text] [Related]

  • 36. Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.
    Kim TW, Hung CF, Ling M, Juang J, He L, Hardwick JM, Kumar S, Wu TC.
    J Clin Invest; 2003 Jul 20; 112(1):109-17. PubMed ID: 12840065
    [Abstract] [Full Text] [Related]

  • 37. [Immunogenicity of mutant and wild HPV16 DNA vaccines].
    Zuo YG, Wang JB, Jin HZ, Yue-hua L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct 20; 26(5):554-7. PubMed ID: 15562771
    [Abstract] [Full Text] [Related]

  • 38. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 20; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 39. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.
    Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC.
    Hum Gene Ther; 2002 Mar 01; 13(4):553-68. PubMed ID: 11874633
    [Abstract] [Full Text] [Related]

  • 40. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.